- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02776449
Pressure Difference Between Brain and Eye: a Possible Cause to Normal Tension Glaucoma.
Pathological Cerebral Venous Drainage System Giving Large Pressure Difference Between Brain and Eye at Upright Posture: a Possible Cause to Normal Tension Glaucoma.
Study Overview
Status
Conditions
Detailed Description
The trans-lamina cribrosa pressure difference (TLCPD), i.e. the difference between the intraocular pressure (IOP) and the intracranial pressure (ICP) has been suggested as a pathophysiological component in glaucoma. The theory is that high TLCPD, either due to elevated IOP or reduced ICP, can cause glaucomatous damage.
Normal tension glaucoma (NTG) patients has been found to have a slightly reduced ICP when measured in horizontal position. However, in a previous study in healthy adult volunteers the investigators have measured TLCPD at supine, sitting and 9 degree head down tilt positions and found that the TLCPD was posture dependent, with the largest difference in the upright position. Since humans are upright approximately two thirds of the day, one can expect that TLCPD in a diurnal perspective is primarily influenced by the ICP in the upright position.
In this study the TLCPD in different positions in patients with NTG will therefore be measured.
The study will be carried out in three parts.
- TLCPD will be investigated by simultaneous measurements of IOP and ICP. For IOP the Applanation resonance tonometer (ART), developed by our research group, will be used. ART is independent of gravitation and possible to use in all body postures. In this study measurements will be performed in supine, sitting and head down tilt positions. ICP is measured continuously during the period of body position changes with a CELDA lumbar pressure measurement apparatus.
- Brain and eye MRI investigation will be performed at a 3 Tesla GE scanner with a new generation 32-channels head coil. The images will be used to measure the cross-section area, the blood flow velocity and the flow direction in the jugular veins, as well as the structural properties of the optic nerve and optic nerve head.
- Ultrasound imaging, using a high-resolution apparatus, will be performed to study the effects of postural changes on the blood flow velocity and the cross-section area of the right and left internal jugular veins and external jugular veins.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Umeå, Sweden, SE-901 85
- Umeå University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subject has normal tension glaucoma in one or both eyes (glaucomatous optic nerve head and corresponding visual field defects)
- Intraocular pressures before treatment did not exceed 21 mmHg. Occasional measurement up to 24 is accepted.
Exclusion Criteria:
- History of brain disease or brain surgery
- History of other neurologic or ocular disease causing visual field loss
- Use of anticoagulants other than acetylsalicylic acid
- Use of carbonic anhydrase inhibitors
- Previous lumbar puncture
- Claustrophobia
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Normal Tension Glaucoma
Patients with manifest normal tension glaucoma
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trans-lamina cribrosa pressure difference (TLCPD)
Time Frame: 1 day Single time point measurement
|
Difference between intraocular pressure (IOP) and intracranial pressure in different body positions
|
1 day Single time point measurement
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Postural changes on blood flow velocity and cross-section area of right and left internal jugular veins (IJV) and external jugular veins (EJV)
Time Frame: 1 day Single time point measurement
|
1 day Single time point measurement
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Retinal perfusion using 3D Phase contrast magnetic resonance imaging (3DPCMRI)
Time Frame: 1 day Single time point measurement
|
1 day Single time point measurement
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jan Malm, MD, Umeå University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NTG-ICP_1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal Tension Glaucoma
-
University of North Carolina, Chapel HillSensimed AGCompletedNormal-Tension GlaucomaUnited States
-
Qlaris Bio, Inc.CompletedNormal Tension Glaucoma (NTG)United States
-
Yu-Ting TsaoCompletedPrimary Open Angle Glaucoma (POAG) | Istent Inject W | Normal Tension Glaucoma (NTG)Taiwan
-
Qlaris Bio, Inc.CompletedGlaucoma | Normal Tension Glaucoma (NTG) | Low-Tension Glaucoma, Bilateral | Low-Tension Glaucoma, Unspecified EyeSouth Korea
-
Technische Universität DresdenCompletedNormal Tension Glaucoma | High Tension Glaucoma
-
Ngoc Nguyen Inc.Alcon ResearchNot yet recruitingGlaucoma | Glaucoma, Open Angle | Open Angle Glaucoma (OAG) | Normal Tension Glaucoma (NTG)United States
-
Salus UniversityNot yet recruitingNormal Tension GlaucomaUnited States
-
Westlake Eye SpecialistsSengiCompletedNormal Tension GlaucomaUnited States
-
Intuor Technologies, Inc.CompletedOcular Hypertension | Glaucoma | Normal Tension GlaucomaUnited States
-
Merck Sharp & Dohme LLCCompleted